血管内治疗后血脑屏障破坏与多次取栓次数的关联
多次取栓患者严重HARM发生率(67% vs 29%)、任何出血转化(60% vs 36%)和不良临床结局(67% vs 36%)均显著更高。严重HARM与多次取栓独立相关(OR 7.2,95%CI 1.93-26.92,P=0.003)。
要点
- 多次取栓患者24小时严重HARM发生率显著高于单次取栓(67% vs 29%)。
- 多次取栓与出血转化和不良临床结局风险增加相关。
- 严重HARM与多次取栓独立相关,OR为7.2。
核心结论
- 多次取栓次数与血管内治疗后24小时检测到的血脑屏障破坏显著增加独立相关。
- 血管内治疗后出现HARM的患者,多次取栓相对于单次取栓的比值比增加超过7倍。
研究设计与样本
- 患者接受或不接受静脉tPA治疗,均同意加入NINDS自然史研究,并在血管内治疗前接受基线MRI。
- 对HARM和出血转化进行共识图像判读,良好临床结局定义为最新可用改良Rankin量表评分0-2分。
主要发现
- 多次取栓患者24小时严重HARM发生率为67%,单次取栓为29%(P=0.001)。
- 多次取栓患者任何出血转化发生率为60%,单次取栓为36%(P=0.04)。
- 多次取栓患者不良临床结局发生率为67%,单次取栓为36%(P=0.008)。
- 仅年龄(OR 1.1,95%CI 1.01-1.12,P=0.022)和血管内治疗后24小时严重HARM(OR 7.2,95%CI 1.93-26.92,P=0.003)与多次取栓显著相关。
关键数值与推荐
- 严重HARM在24小时评估,多次取栓组67% vs 单次取栓组29%(P=0.001)。
- 任何出血转化多次取栓组60% vs 单次取栓组36%(P=0.04)。
- 不良临床结局(mRS 0-2)多次取栓组67% vs 单次取栓组36%(P=0.008)。
- 年龄与多次取栓相关OR 1.1(95%CI 1.01-1.12,P=0.022)。
- 严重HARM与多次取栓相关OR 7.2(95%CI 1.93-26.92,P=0.003)。
临床怎么用
- 血管内治疗后24小时HARM提示血脑屏障破坏,需关注出血转化风险。
- 多次取栓患者应加强术后影像监测和临床评估。
- 严重HARM可作为多次取栓后血脑屏障破坏的影像标志物。
局限性
- 研究仅纳入前循环急性缺血性卒中患者,结果外推受限。
- HARM和出血转化通过共识图像判读评估,可能存在判读偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The high prevalence of hyperintense acute reperfusion marker (HARM) seen after endovascular therapy is suggestive of blood-brain barrier disruption and hemorrhage risk and may be attributable to multiple thrombectomy passes needed to achieve recanalization. Methods- Patients with acute stroke were included if they were screened from January 2015 through February 2019, received an acute ischemic stroke diagnosis involving the anterior circulation, treated with or without IV tPA (intravenous tissue-type plasminogen activator), consented to the NINDS Natural History Study, and imaged with a baseline magnetic resonance imaging before receiving endovascular therapy. Consensus image reads for HARM and hemorrhagic transformation were performed. Good clinical outcome was defined as 0-2 using the latest available modified Rankin Scale score. Results- Eighty patients met all study criteria and were included in the analyses. Median age was 65 years, 64% female, 51% black/African American, median admit National Institutes of Health Stroke Scale=19, 56% treated with IV tPA, and 84% achieved Thrombolysis in Cerebral Infarction score of 2b/3. Multiple-pass patients had significantly higher rates of severe HARM at 24 hours (67% versus 29%; P=0.001), any hemorrhagic transformation (60% versus 36%; P=0.04) and poor clinical outcome (67% versus 36%; P=0.008). Only age (odds ratio, 1.1; 95% CI, 1.01-1.12; P=0.022) and severe HARM at 24 hours post-endovascular therapy were significantly associated with multiple passes (odds ratio, 7.2; 95% CI, 1.93-26.92; P=0.003). Conclusions- In this exploratory study, multiple thrombectomy passes are independently associated with a significant increase in blood-brain barrier disruption detected at 24 hours. Patients with HARM post-endovascular therapy had a >7-fold increase in the odds of having multiple- versus single-pass thrombectomy. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT00009243.
引用
- Luby M, Hsia AW, Nadareishvili Z, et al. Frequency of Blood-Brain Barrier Disruption Post-Endovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients. Stroke. 2019. PMID: 31238832. doi:10.1161/STROKEAHA.119.025914
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。